NCT07426055 2026-03-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Recruiting
Clinical Trials
89 trialsNCT07426094 2026-03-23
PRO-BOOST-N
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Recruiting
NCT06282588 2026-03-19
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
NCT05597878 2026-03-06
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
Phase 2/3 Suspended
NCT03495427 2026-03-02
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
H. Lee Moffitt Cancer Center and Research Institute
Phase 2/3 Recruiting
NCT03070886 2026-01-14
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
NRG Oncology
Phase 2/3 Completed
NCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
NCT03701581 2025-12-17
4-aminopyridine Treatment for Nerve Injury
University of Arizona
Phase 2/3 Recruiting
NCT06851663 2025-12-08
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
Phase 2/3 Recruiting
NCT05786716 2025-12-02
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05770037 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT06861192 2025-11-18
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Zhongda Hospital
Phase 2/3 Recruiting
NCT04263025 2025-10-22
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft
Hackensack Meridian Health
Phase 2/3 Recruiting
NCT03772834 2025-10-10
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT06196853 2025-10-07
Prevention of Cisplatin-induced Nephrotoxicity
Mahidol University
Phase 2/3 Not yet recruiting
NCT07209878 2025-10-07
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
Phase 2/3 Recruiting
NCT07198451 2025-09-30
GEM-IR-NMIBC
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Not yet recruiting
NCT07156786 2025-09-19
N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial
Fakultas Kedokteran Universitas Indonesia
Phase 2/3 Not yet recruiting
NCT06124976 2025-09-15
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
University of British Columbia
Phase 2/3 Recruiting
NCT05137561 2025-08-07
PROBIOP
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3 Completed
NCT06537154 2025-07-30
NEO-BLAST
University of British Columbia
Phase 2/3 Recruiting
NCT05920343 2025-07-10
PREVENT-GU
Ottawa Hospital Research Institute
Phase 2/3 Recruiting
NCT06972511 2025-05-15
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
RenJi Hospital
Phase 2/3 Recruiting
NCT03822845 2025-04-17
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT03525288 2025-03-13
PSMA-PETgRT
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2/3 Active not recruiting
NCT06861166 2025-03-06
Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Zhongda Hospital
Phase 2/3 Not yet recruiting
NCT02984124 2025-02-18
CHART
University of Vermont
Phase 2/3 Active not recruiting
NCT02685397 2024-12-04
PCS IX
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Active not recruiting
NCT06601205 2024-09-19
2F
Ente Ospedaliero Ospedali Galliera
Phase 2/3 Completed
NCT03389451 2024-07-12
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer
University of Iowa
Phase 2/3 Completed
NCT03755739 2024-06-25
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT05627752 2024-02-28
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Zhongnan Hospital
Phase 2/3 Unknown
NCT03388346 2024-02-15
68Ga PSMA in Preprostatectomy Patients
University of Iowa
Phase 2/3 Completed
NCT04242017 2023-12-13
LOBSTER
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Recruiting
NCT03459820 2023-11-27
Prostate Cancer Patient Management With 18F-DCFPyL PET/CT
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Enrolling by invitation
NCT00584532 2023-11-24
GCP
University of California, Davis
Phase 2/3 Completed
NCT01666808 2023-08-02
FACBC Outcomes for Post Prostatectomy
Emory University
Phase 2/3 Completed
NCT04654338 2023-06-27
EARTH
Sunnybrook Health Sciences Centre
Phase 2/3 Recruiting
NCT05841992 2023-05-03
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
Peking Union Medical College Hospital
Phase 2/3 Unknown
NCT01907009 2023-04-19
MEL-CAP
Barts & The London NHS Trust
Phase 2/3 Terminated
NCT02624518 2023-04-10
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Stanford University
Phase 2/3 Completed
NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT04627896 2023-02-02
Targeted Microwave Focal Therapy
A.O.U. Città della Salute e della Scienza
Phase 2/3 Completed
NCT03879122 2022-10-26
A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer
Spanish Oncology Genito-Urinary Group
Phase 2/3 Unknown
NCT01869413 2022-10-04
TACT
Ottawa Hospital Research Institute
Phase 2/3 Completed
NCT04796467 2022-08-09
68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
Peking Union Medical College Hospital
Phase 2/3 Unknown
NCT03824275 2022-05-11
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer
Columbia University
Phase 2/3 Active not recruiting
NCT02678351 2022-03-04
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery
Stanford University
Phase 2/3 Completed
NCT02673151 2022-01-13
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Stanford University
Phase 2/3 Completed
NCT03800784 2021-12-15
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2/3 Withdrawn